Conway Robert E
- SEC CIK
- 0001184334
No open-market purchases or sales filed in the past year.
Current role at each company
- CIK 0001626199Directoras of May 20, 2024
- ORKA Oruka Therapeutics, Inc.Director, Other: Chairman of the Boardas of Jan 31, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Conway Robert E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CIK 0001626199
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2021 (view filing) | Sep 23 | 4 days | Conway Robert EDirector | PPurchase | +15.0K | $10.08 | +$151.2K | +42.9%50.0K after | Amended |
| Sep 23, 2021 (view filing) | Sep 21 | 2 days | Conway Robert EDirector | PPurchase | +10.0K | $9.80 | +$98.0K | +40.0%35.0K after |